Zachary A Schiller
Overview
Explore the profile of Zachary A Schiller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Q, Humphries F, Girardin R, Wallace A, Ejemel M, Amcheslavsky A, et al.
Front Immunol
. 2022 Sep;
13:995412.
PMID: 36172366
Anti-COVID antibody therapeutics have been developed but not widely used due to their high cost and escape of neutralization from the emerging variants. Here, we describe the development of VHH-IgA1.1,...
2.
Schiller Z, Rudolph M, Toomey J, Ejemel M, LaRochelle A, Davis S, et al.
J Clin Invest
. 2021 Apr;
131(11).
PMID: 33914704
Disrupting transmission of Borrelia burgdorferi sensu lato complex (B. burgdorferi) from infected ticks to humans is one strategy to prevent the significant morbidity from Lyme disease. We have previously shown...
3.
Amcheslavsky A, Wallace A, Ejemel M, Li Q, McMahon C, Stoppato M, et al.
Sci Rep
. 2021 Feb;
11(1):2751.
PMID: 33531570
Enterotoxigenic Escherichia coli (ETEC) is estimated to cause approximately 380,000 deaths annually during sporadic or epidemic outbreaks worldwide. Development of vaccines against ETEC is very challenging due to the vast...
4.
Ejemel M, Gawron M, Schneider M, Wallace A, Schiller Z, Schneider R, et al.
Monoclon Antib Immunodiagn Immunother
. 2020 Oct;
39(6):228-232.
PMID: 33121367
Immunoglobulin A (IgA) antibodies are critical to mucosal protection, specifically dimeric IgA (dIgA) and secretory IgA (sIgA), which rely on the J chain to polymerize. There is an absence of...
5.
Ejemel M, Li Q, Hou S, Schiller Z, Tree J, Wallace A, et al.
Nat Commun
. 2020 Aug;
11(1):4198.
PMID: 32826914
COVID-19 caused by SARS-CoV-2 has become a global pandemic requiring the development of interventions for the prevention or treatment to curtail mortality and morbidity. No vaccine to boost mucosal immunity,...
6.
Ejemel M, Li Q, Hou S, Schiller Z, Wallace A, Amcheslavsky A, et al.
bioRxiv
. 2020 Jun;
PMID: 32511396
COVID-19 caused by SARS-CoV-2 has become a global pandemic requiring the development of interventions for the prevention or treatment to curtail mortality and morbidity. No vaccine to boost mucosal immunity...
7.
Stoppato M, Gaspar C, Regeimbal J, Nunez R, Giuntini S, Schiller Z, et al.
Vaccine
. 2020 Feb;
38(10):2333-2339.
PMID: 32008877
Enterotoxigenic Escherichia coli (ETEC) is a leading cause of diarrhea-associated illness in developing countries. There is currently no vaccine licensed to prevent ETEC and the development of an efficacious prophylaxis...
8.
Wang Y, Esquivel R, Flingai S, Schiller Z, Kern A, Agarwal S, et al.
J Infect Dis
. 2018 Nov;
219(7):1146-1150.
PMID: 30476132
We recently developed anti-OspA human immunoglobulin G1 monoclonal antibodies (HuMAbs) that are effective in preventing Borrelia transmission from ticks in a murine model. Here, we investigated a novel approach of...
9.
Giuntini S, Stoppato M, Sedic M, Ejemel M, Pondish J, Wisheart D, et al.
Infect Immun
. 2018 Nov;
86(12).
PMID: 30459206
No abstract available.
10.
Giuntini S, Stoppato M, Sedic M, Ejemel M, Pondish J, Wisheart D, et al.
Infect Immun
. 2018 Jun;
86(8).
PMID: 29866909
Enterotoxigenic (ETEC) causes diarrheal illness in infants in the developing world and travelers to countries where the disease is endemic, including military personnel. ETEC infection of the host involves colonization...